11
Participants
Start Date
December 31, 2012
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
Volulyte
6 % hydroxyethyl starch 130/0.4 in an isotonic electrolyte solution will be intravenously infused in order to achieve and maintain predefined hemodynamics goals and may be given up to a total daily dose of 50 mL/kg body weight/day.
Human Serum Albumin
5% Human Serum Albumin will be intravenously infused in order to achieve and maintain predefined hemodynamics goals with no daily dose limit.
University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Queen Elizabeth Medical Centre, Birmingham
Lead Sponsor
Fresenius Kabi
INDUSTRY